🔗 Share this article

Texas Attorney General Paxton is suing the makers of Tylenol, asserting the corporations concealed potential risks that the medication posed to pediatric brain development.

The lawsuit follows thirty days after President Donald Trump publicized an unsubstantiated connection between using Tylenol - alternatively called acetaminophen - while pregnant and autism spectrum disorder in children.

The attorney general is taking legal action against Johnson & Johnson, which formerly manufactured the medication, the sole analgesic approved for pregnant women, and the current manufacturer, which currently produces it.

In a declaration, he claimed they "deceived the public by making money from pain and marketing drugs regardless of the potential hazards."

The manufacturer asserts there is lacking scientific proof connecting Tylenol to autism.

"These manufacturers lied for decades, intentionally threatening countless individuals to boost earnings," Paxton, from the Republican party, stated.

The company said in a statement that it was "deeply concerned by the perpetuation of misinformation on the safety of acetaminophen and the likely effects that could have on the health of American women and children."

On its online platform, the company also said it had "consistently assessed the relevant science and there is lacking reliable evidence that shows a established connection between using paracetamol and autism spectrum disorder."

Groups acting on behalf of medical professionals and health professionals agree.

The leading OB-GYN organization has declared paracetamol - the primary component in Tylenol - is one of the few options for pregnant women to manage discomfort and elevated temperature, which can create significant medical dangers if ignored.

"In more than two decades of research on the use of acetaminophen in gestation, no reliable research has conclusively proven that the use of paracetamol in any period of gestation causes neurodevelopmental disorders in offspring," the organization commented.

This legal action references recent announcements from the former administration in claiming the medication is potentially dangerous.

In recent weeks, the former president raised alarms from health experts when he told women during pregnancy to "resist strongly" not to take acetaminophen when sick.

The US Food and Drug Administration then released a statement that medical professionals should consider limiting the use of acetaminophen, while also declaring that "a proven link" between the medication and autism spectrum disorder in young ones has not been proven.

The Health Department head Kennedy, who oversees the FDA, had vowed in spring to conduct "extensive scientific investigation" that would identify the cause of autism in a limited time.

But specialists warned that discovering a single cause of autism spectrum disorder - considered by experts to be the outcome of a complex mix of inherited and environmental factors - would be difficult.

Autism spectrum disorder is a type of lifelong neurodivergence and impairment that affects how persons encounter and interact with the environment, and is identified using doctors' observations.

In his legal document, Paxton - a Trump ally who is seeking federal office - asserts Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the research" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the corporations "eliminate any commercial messaging" that claims acetaminophen is safe for pregnant women.

The Texas lawsuit echoes the complaints of a assembly of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in recently.

Judicial authorities threw out the case, declaring studies from the parents' expert witnesses was inconclusive.